Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CYRX Stock Chart & Stats
$9.21
$0.06(0.70%)
At close: 4:00 PM EST
$9.21
$0.06(0.70%)
Day’s Range― - ―
52-Week Range$4.58 - $11.44
Previous CloseN/A
Volume42.91K
Average Volume (3M)690.07K
Market Cap
$466.64M
Enterprise Value$215.74M
Total Cash (Recent Filing)$421.31M
Total Debt (Recent Filing)$230.86M
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Mar 11, 2026EPS Estimate
-0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding50,068,905
10 Day Avg. Volume860,552
30 Day Avg. Volume690,069
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.94
Price to Sales (P/S)1.63
P/FCF Ratio-11.29
Enterprise Value/Market Cap0.46
Enterprise Value/Revenue1.13
Enterprise Value/Gross Profit2.43
Enterprise Value/Ebitda-15.30
Forecast
1Y Price Target
$13.63Price Target Upside47.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercial RevenueCommercial revenue increased by an impressive 36% and contributed significantly to total revenue, highlighting the company's growth potential.
Market OutlookThe market for CryoPort Inc is improving, with a growing number of FDA approvals for cell and gene therapy products, which is expected to benefit the company's financial performance.
Revenue GrowthRevenue of $44.2M was well ahead of consensus estimates, driven by both Life Sciences Services and Life Sciences Products, signaling strong demand recovery.
Bears Say
CryoPort News
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $4.58 and its highest was $11.44 in the past 12 months.
What is CryoPort Inc’s market cap?
CryoPort Inc’s market cap is $466.64M.
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is Mar 11, 2026 which is in 81 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Nov 04, 2025. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.223 by $0.043.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -0.21.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 50,068,905 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.223. Following the earnings report the stock price went down -7.484%.
Which hedge fund is a major shareholder of CryoPort Inc?
Currently, no hedge funds are holding shares in CYRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CryoPort Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.63 (47.99% Upside)
$13.63 (47.99% Upside)
Crowd Wisdom
Negative
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.93%
12-Months-Change
Fundamentals
Return on Equity
-9.96%
Trailing 12-Months
Asset Growth
-9.20%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. is a logistics company specializing in temperature-controlled shipping solutions for the life sciences industry, particularly in the fields of biopharmaceuticals and regenerative medicine. The company provides a range of services including cryogenic storage, transportation, and related logistics support for sensitive biological materials. CryoPort's core products include its CryoPort Express® shipping solutions, CryoPort Express® systems, and associated monitoring technologies, which ensure the safe and reliable transport of critical biological samples and products.
CYRX Company Deck
CYRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a mostly positive outlook with strong growth in key segments, strategic expansions, and increased clinical trial support. However, there are some concerns about sequential revenue guidance and external factors like the government shutdown impacting operations.View all CYRX earnings summariesCYRX Stock 12 Month Forecast
Average Price Target
$13.63
▲(47.99% Upside)
Technical Analysis
Ownership Overview
3.38% Insiders
17.65% Mutual Funds
36.92% Other Institutional Investors
24.30% Public Companies and
Individual Investors